Localized prostate cancer
Long Term Outcomes and Prognosis of Transrectal High Intensity Focused Ultrasound Therapy for Patients with Localized Prostate Cancer—Therapy after Recurrence and Predictive Factors
... of prostate cancer worldwide, the pro- portion of early stage prostate cancer has ...of localized prostate ...for localized prostate cancer [6] ...with ...
17
Personal preferences and discordant prostate cancer treatment choice in an intervention trial of men newly diagnosed with localized prostate cancer
... with prostate cancer each year in the United States (US), of whom 90% are classified as having clinically localized prostate cancer (LPC) ...
8
Considering racial and ethnic preferences in communication and interactions among the patient, family member, and physician following diagnosis of localized prostate cancer: study of a US population
... and Cancer Therapy Selection (FACTS) study, a multisite study designed to prospectively examine the treatment decision-making process of patients newly diagnosed with localized pros- tate cancer, ...
6
Patient educational technologies and their use by patients diagnosed with localized prostate cancer
... Upon being diagnosed with localized prostate cancer, pa- tients are “ prescribed ” access to the PET library. Non- English language patients or patients with cognitive deficits are still offered ...
7
<p>The accumulation of metabolic syndrome components is associated with higher risk of positive surgical margin among patients with localized prostate cancer after radical prostatectomy</p>
... The accumulation of metabolic syndrome components is associated with higher risk of positive surgical margin among patients with localized prostate cancer after radical prostatectomy[r] ...
8
The feasibility and safety of repeat cryosurgical ablation of localized prostate cancer
... of cancer at biopsy with a Gleason score of 8 and 5 years of neoadjuvant hormone therapy; thus, this patient had a poor prognosis and benefit from other kinds of therapies was ...no cancer, and his PSA ...
6
Low Temperature Plasma : A Novel Focal Therapy for Localized Prostate Cancer?
... of localized prostate cancer, high recurrence rates and detrimental side efects are still a cause for ...onset prostate cancer: low temperature ...on prostate cancer, ...
17
Personal prostate specific antigen screening and treatment choices for localized prostate cancer among expert physicians
... We developed a survey to assess physicians’ personal choices (for men) and recommendations to relatives (for women) regarding PSA screening and treatment of localized prostate cancer. The survey was ...
11
Treatment options for localized prostate cancer
... stage prostate cancer: radical prostatectomy (RP), prostate brachy- therapy (PB), external beam radiation therapy (EBRT), and active surveillance ...with prostate cancer patients ...
6
Helping patients with localized prostate cancer reach treatment decisions
... managing localized prostate cancer has not been established and currently includes a number of potential options: active surveillance, radical prostatec- tomy, external beam radiotherapy, ...
5
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics
... Localized prostate cancer (PCa) is a clinically heterogeneous disease, which presents with variability in patient outcomes within the same risk stratification (low, intermediate or high) and even ...
7
Active surveillance for the management of localized prostate cancer: Guideline recommendations
... with localized prostate ...repeat prostate biopsies in the AS protocol; however, the frequency of these tests varied significantly between stud- ...
8
The Impact of Variation in Bladder Volume on the Doses of Target and Organ at Risk in Intensity Modulated Radiation Therapy for Localized Prostate Cancer
... Prostate cancer is the most common cancer in men, and intensity-modulated radiation therapy (IMRT) has become the mainstay of treatment for localized prostate ...
11
Is there an optimal management for localized prostate cancer?
... with prostate-specific antigen (PSA) has led to a signifi- cant increase in the detection of early stage, clinically localized prostate cancer ...for localized CaP are discussed in this ...
11
<p>Moderate hypofractionated radiotherapy vs conventional fractionated radiotherapy in localized prostate cancer: a systemic review and meta-analysis from Phase III randomized trials</p>
... We regarded studies as eligible for inclusion if they are randomized Phase III clinical trials comparing H-RT with C-RT in patients with localized prostate cancer without sur- gery. Exclusion ...
10
The EEF1A2 gene expression as risk predictor in localized prostate cancer
... In hepatocellular carcinoma EEF1A2 was shown to inactivate P53 via an upstream activation of the PI3K/ AKT/mTOR-pathway [25]. This gives rationale to a druggability of EEF1A2-dependent tumor growth in PCa with mTOR ...
9
Personal prostate specific antigen screening and treatment choices for localized prostate cancer among expert physicians
... population-level prostate cancer screening due to bias, financial interest, and other ulterior motives; however, these physicians would be unlikely to personally opt for prostate cancer ...
5
Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients
... treatment of localized PCa in elderly patients was expected. Our results confirmed some of our hypotheses. Specifically, the two main treatment modalities used in patients aged ≥80 years were CM and PADT. ...
7
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.
... Appendix. Prostate-cancer–specific mortality is reported with 95% confidence intervals for each treatment group, and pairwise significance tests were planned if a test of the null hypothesis of no ...
11
Treatment trends and Medicare reimbursements for localized prostate cancer in elderly patients
... similar cancer control outcomes in such selectively identified individuals, compared to their younger ...of cancer related causes is ...for localized PCa, in any patient including those aged ≥ 80 ...
19